Address
Email address
Phone number
Website
https://www.itk.eeAvaleht | Ida-Tallinna KeskhaiglaIda-Tallinna Keskhaigla koosseisu kuulub 7 kliinikut, mis asuvad mitmes üksuses üle Tallinna linna. Meie kliinikud on: Diagnostikakliinik, Kirurgiakliinik, Hooldusravikliinik, Naistekliinik, Silmakliinik, Sisekliinik, Taastusravikliinik.
Name
Aktsiaselts Ida-Tallinna Keskhaigla
Registry code
10822068
VAT number
EE100733701
Type
AS - Joint Stock Company
Status
Registered
Foundation date
13.12.2001 (22)
Financial year
01.01-31.12
Capital
16 754 700.00 €
Activity
6820 - Rental and operating of own or leased real estate 86101 - Hospitalisation services
141 558 451 €
1 588 172 €
1%
2 262 €
(estimate is approximate)
30 277 312 €
2163
Submitted
No tax arrears
5%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tallinna Linnakantselei 75014920 | 100% - 16 754 700.00 EUR | - | - | FounderShareholder |
| Kai Sukles 09.04.1966 (58) | - | Board member | - | |
| Kätlin Pallo 16.06.1982 (41) | - | Board member | - | |
| Tarmo Bakler 13.05.1970 (54) | - | Board member | - | |
| Betina Beškina 24.12.1986 (37) | - | - | Right to appoint or recall the majority of the executive management or higher management members | Board member |
| Joosep Vimm 08.02.1990 (34) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Kaarel Oja 21.04.1985 (39) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Madle Lippus 11.10.1984 (39) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Vladimir Svet 11.03.1992 (32) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Andrei Kante 28.03.1986 (38) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Tiit Terik 15.06.1979 (44) | - | - | Right to appoint or recall the majority of the executive management or higher management members | |
| Aleksandr Zdankevitš 20.08.1985 (38) | - | - | - | Board member |
| Jaanus Riibe 18.06.1986 (37) | - | - | - | Board member |
| Karmo Kuri 27.08.1987 (36) | - | - | - | Board member |
| Tanel Kiik 23.01.1989 (35) | - | - | - | Board member |
| Kairi Vaher 21.07.1971 (52) | - | - | - | Chairman of the board |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Mittetulundusühing Eesti Meditsiiniekspordi Klaster 80398850 | - | - | - | Founder (without contribution) |
| 2020 25.06.2021 | 2021 24.06.2022 | 2022 02.06.2023 | |
|---|---|---|---|
| Total Revenue | 127 682 279 € | 137 687 410 € | 141 558 451 € |
| Net profit (loss) for the period | 5 576 432 € | 4 816 405 € | 1 588 172 € |
| Profit Margin | 4% | 3% | 1% |
| Current Assets | 17 881 876 € | 18 405 446 € | 21 119 345 € |
| Fixed Assets | 34 148 800 € | 39 860 431 € | 46 533 588 € |
| Total Assets | 52 030 676 € | 58 265 877 € | 67 652 933 € |
| Current Liabilities | 17 746 791 € | 20 016 261 € | 20 376 802 € |
| Non Current Liabilities | 10 411 150 € | 9 560 476 € | 16 998 819 € |
| Total Liabilities | 28 157 941 € | 29 576 737 € | 37 375 621 € |
| Share Capital | 16 754 700 € | 16 754 700 € | 16 754 700 € |
| Equity | 23 872 735 € | 28 689 140 € | 30 277 312 € |
| Employees | 2205 | 2198 | 2163 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q4 | 2 205 239.75 € | 8 705 824.82 € | 8 969 267.49 € | 2599 |
| 2023 Q3 | 1 386 999.52 € | 9 272 978.13 € | 9 682 936.32 € | 2558 |
| 2023 Q2 | 1 741 898.41 € | 7 839 782.16 € | 8 136 115.36 € | 2573 |
| 2023 Q1 | 1 471 110.66 € | 7 684 717.51 € | 7 957 596.49 € | 2507 |
| 2022 Q4 | 1 530 310.81 € | 7 347 570.08 € | 7 575 180.62 € | 2495 |
| 2022 Q3 | 1 350 466.31 € | 7 701 698.2 € | 8 045 340.49 € | 2494 |
| 2022 Q2 | 1 327 757.86 € | 7 108 704.04 € | 7 392 649.01 € | 2492 |
| 2022 Q1 | 1 242 649.09 € | 7 260 426.41 € | 7 541 351.07 € | 2505 |
| 2021 Q4 | 1 240 086.89 € | 6 617 565.01 € | 6 864 754.78 € | 2514 |
| 2021 Q3 | 1 101 869.48 € | 7 459 517.85 € | 7 845 439.61 € | 2549 |
| 2021 Q2 | 1 274 999.43 € | 6 911 553.67 € | 7 221 386.77 € | 2538 |
| 2021 Q1 | 1 120 955.01 € | 6 491 257.94 € | 6 717 978.31 € | 2521 |
| 2020 Q4 | 1 136 428.13 € | 5 991 634.93 € | 6 282 141.83 € | 2507 |
| 2020 Q3 | 924 393.29 € | 6 444 419.85 € | 6 821 528.04 € | 2537 |
| 2020 Q2 | 853 287.24 € | 5 889 469.59 € | 6 216 974.16 € | 2517 |
| 2020 Q1 | 1 077 216.63 € | 6 005 535.52 € | 6 292 441.45 € | 2476 |
